New analysis explains why bone marrow cancer T cells may need therapeutic activation
Researchers from German Cancer Research Center and partnered institutes have studied T cells in bone marrow of patients with multiple myeloma and acute myeloid leukemia. Their findings, published in Cancer Cell, suggest that therapeutic activation of these T cells may be necessary for effective treatment.
bone marrow T cells multiple myeloma acute myeloid leukemia therapeutic activation
Linked Entities
Contributing Articles
[Review] Advancing the relevance of clinical trials for older patients
The Lancet —
[Articles] Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial
The Lancet —
[Articles] Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study
The Lancet —
GLP-1s: New daily weight loss pill Foundayo approved by UK regulator
BMJ News —
Pilule antiobésité : le Foundayo, développé par le laboratoire américain Eli Lilly, autorisé au Royaume-Uni, une première en Europe
Le Monde —
New analysis explains why bone marrow cancer T cells may need therapeutic activation
Medical Xpress —